These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 24290869)

  • 1. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L; Bendtsen F; Hansen EF; Møller S
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of carvedilol a nonselective beta-blocker on portal hemodynamics in cirrhosis.
    Fierbinteanu-Braticevici C; Udeanu M; Dragomir P; Andronescu D
    Rom J Intern Med; 2003; 41(3):247-54. PubMed ID: 15526508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol or propranolol in portal hypertension? A randomized comparison.
    Hobolth L; Møller S; Grønbæk H; Roelsgaard K; Bendtsen F; Feldager Hansen E
    Scand J Gastroenterol; 2012 Apr; 47(4):467-74. PubMed ID: 22401315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis.
    Forrest EH; Bouchier IA; Hayes PC
    J Hepatol; 1996 Dec; 25(6):909-15. PubMed ID: 9007720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
    Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
    Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension.
    Sekiyama T; Komeichi H; Nagano T; Ohsuga M; Terada H; Katsuta Y; Satomura K; Aramaki T
    Arzneimittelforschung; 1997 Apr; 47(4):353-5. PubMed ID: 9150854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis.
    Sinagra E; Perricone G; D'Amico M; Tinè F; D'Amico G
    Aliment Pharmacol Ther; 2014 Mar; 39(6):557-68. PubMed ID: 24461301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.
    Kim SG; Kim TY; Sohn JH; Um SH; Seo YS; Baik SK; Kim MY; Jang JY; Jeong SW; Lee B; Kim YS; Suk KT; Kim DJ
    Am J Gastroenterol; 2016 Nov; 111(11):1582-1590. PubMed ID: 27575713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial.
    Shah HA; Azam Z; Rauf J; Abid S; Hamid S; Jafri W; Khalid A; Ismail FW; Parkash O; Subhan A; Munir SM
    J Hepatol; 2014 Apr; 60(4):757-64. PubMed ID: 24291366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effect of carvedilol vs. propranolol in cirrhotic patients: Systematic review and meta-analysis.
    Aguilar-Olivos N; Motola-Kuba M; Candia R; Arrese M; Méndez-Sánchez N; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2014; 13(4):420-8. PubMed ID: 24927613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics.
    De BK; Das D; Sen S; Biswas PK; Mandal SK; Majumdar D; Maity AK
    J Gastroenterol Hepatol; 2002 Feb; 17(2):183-9. PubMed ID: 11966949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
    Braillon A; Calès P; Lebrec D
    Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis.
    Li T; Ke W; Sun P; Chen X; Belgaumkar A; Huang Y; Xian W; Li J; Zheng Q
    BMJ Open; 2016 May; 6(5):e010902. PubMed ID: 27147389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes.
    Bruha R; Vitek L; Petrtyl J; Lenicek M; Urbanek P; Zelenka J; Jachymova M; Svestka T; Kalab M; Dousa M; Marecek Z
    Scand J Gastroenterol; 2006 Dec; 41(12):1454-63. PubMed ID: 17101577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
    Bañares R; Moitinho E; Matilla A; García-Pagán JC; Lampreave JL; Piera C; Abraldes JG; De Diego A; Albillos A; Bosch J
    Hepatology; 2002 Dec; 36(6):1367-73. PubMed ID: 12447861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
    Aramaki T; Sekiyama T; Katsuta Y; Kurokawa H; Komeichi H; Tsutsui H; Terada H; Ohsuga M; Satomura K; Okumura H
    J Hepatol; 1992 May; 15(1-2):48-53. PubMed ID: 1354676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta-adrenergic blockade on elevated arterial compliance and low systemic vascular resistance in cirrhosis.
    Møller S; Bendtsen F; Henriksen JH
    Scand J Gastroenterol; 2001 Jun; 36(6):653-7. PubMed ID: 11424326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.